Philips settles suits over its DreamStation sleep apnea machines for $1.1 billion
Dutch medical device maker Philips said Monday it had reached a $1.1 billion deal in the United States to settle lawsuits over faulty sleep machines in a case that have dogged the company.
The company's stock soared on news of the settlement, which was less onerous than feared by some shareholders.
Since 2021, Philips has been battling a series of crises over its DreamStation machines for sleep apnea, a disorder in which breathing stops and starts during sleep.
Earlier this year, the company said it would halt new sales of the machines in the United States following a series of recalls of the devices made by subsidiary Philips Respironics.
Philips said in a statement Monday that it had reached an agreement with the plaintiffs "to resolve the personal injury litigation and the medical monitoring class action to end the uncertainty associated with litigation in the U.S.," adding that it didn't "admit any fault or liability, or that any injuries were caused by Respironics' devices."
The agreement addresses claims filed in U.S. courts and other potential cases, it said.
Analysts at the Jefferies investment firm said in a note that the settlement was "much milder than feared and shall mark the end of litigation uncertainty".
Shares in Philips surged by more than 33 percent on the Amsterdam stock exchange following the announcement.
"Patient safety and quality is our highest priority, and we have taken important steps in further resolving the consequences of the Respironics recall," Philips chief executive Roy Jakobs said in the company statement.
"The remediation of the sleep therapy devices for patients is almost complete, and the test results to date show the use of these devices is not expected to result in appreciable harm to health," he said.
"We do regret the concern that patients may have experienced," he said, adding that the settlements were "significant milestones and provide further clarity on the way forward for Philips."
Philips, which has had to cut thousands of jobs, posted losses of 463 million euros ($501 million) over the full year in 2023.
It reported a loss on Monday of 824 million euros in the first quarter of this year on sales totaling 4.1 billion euros.
Philips said the settlement payments are expected to take place in 2025 and will be funded through cash flow generation.
The company said it had booked a provision of 982 million euros ($1.05 billion) in the first quarter to cover the settlement.
Philips said it also concluded an agreement with insurers to pay Philips 540 million euros to cover Respironics recall-related claims.
"The three biggest litigation cases that we had are now put behind us," Jakobs said in a conference call.
"We can move on and that's very important," he said, while cautioning that it "doesn't mean that everything is resolved."
Franco-German bank Oddo BHF said that "with the long tail of remaining legal risks being very manageable, we believe the settlement today materially derisks the investment case."
相关文章
- 水产品占“四席”!广州南沙十个农产品上榜“国字号”_南方+_南方plus近日,农业农村部农产品质量安全中心公示2024年第二批全国名特优新农产品名录,南沙东涌果蔗入选“全国名特优新农产品”名录。据悉,2024-09-22
Pedri masterclass sends Barca second
BARCELONA:A wonder goal from Pedri proved the difference for Barcelona on Sunday as a 1-0 win over S2024-09-22- BERLIN:A mix-up involving Bayern Munich substitutes that saw the champions play with 12 men for a fe2024-09-22
U.S., N. Korea had exchanged views over peace treaty talks
The United States exchanged views with North Korea over Pyongyang's proposal to hold peace treaty ta2024-09-22- Benedict Nguyễn ,July 24, 2024 Game PlanHo2024-09-22
Blac Chyna and Rob Kardashian had their dream baby
Blac Chyna and Rob Kardashian had a Dream. The on-and-off again reality star couple welcomed a baby2024-09-22
最新评论